We are live on ! Find out more
RBC

Roble Belko & Company Portfolio holdings

AUM $925M
1-Year Est. Return 19.7%
This Fund
S&P 500
This Quarter Est. Return
-4.44%
1 Year Est. Return
+19.7%
3 Year Est. Return
+53.27%
5 Year Est. Return
+47.85%
10 Year Est. Return
+149.75%
AUM
$526M
AUM Growth
-$6.28M
Cap. Flow
+$19M
Cap. Flow %
3.61%
Top 10 Hldgs %
52.4%
Holding
409
New
43
Increased
73
Reduced
62
Closed
21

Top Buys

Rank Stock Value
1
JPST icon
JPMorgan Ultra-Short Income ETF
JPST
+$13.9M
2
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$8.61M
3
VXUS icon
Vanguard Total International Stock ETF
VXUS
+$3.12M
4
VWO icon
Vanguard FTSE Emerging Markets ETF
VWO
+$3.06M
5
KREF
KKR Real Estate Finance Trust
KREF
+$2.22M

Top Sells

Rank Stock Value
1
VUSB icon
Vanguard Ultra-Short Bond ETF
VUSB
+$16M
2
VEU icon
Vanguard FTSE All-World ex-US ETF
VEU
+$4.72M
3
ICSH icon
iShares Ultra Short Duration Bond Active ETF
ICSH
+$2.16M
4
SCHB icon
Schwab US Broad Market ETF
SCHB
+$1.94M
5
NEAR icon
iShares Short Maturity Bond ETF
NEAR
+$1.05M

Sector Composition

Rank Sector Weight
1 Real Estate 3.13%
2 Consumer Discretionary 1.62%
3 Technology 1.26%
4 Healthcare 0.5%
5 Industrials 0.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VHT icon
176
Vanguard Health Care ETF
VHT
$18.6B
$39K 0.01%
155
– –
NVS icon
177
Novartis
NVS
$297B
$38K 0.01%
436
-5
-1% -$433
BMY icon
178
Bristol-Myers Squibb
BMY
$132B
$37K 0.01%
510
+250
+96% +$16.8K
ETSY icon
179
Etsy
ETSY
$7.85B
$37K 0.01%
300
– –
GSK icon
180
GSK
GSK
$106B
$37K 0.01%
686
– –
DBEF icon
181
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.39B
$35K 0.01%
930
– –
PAYC icon
182
Paycom
PAYC
$9.69B
$35K 0.01%
102
– –
AZN icon
183
AstraZeneca
AZN
$250B
$34K 0.01%
260
– –
SLCA
184
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$34K 0.01%
1,800
– –
SBUX icon
185
Starbucks
SBUX
$120B
$33K 0.01%
364
+226
+164% +$21.3K
IAU icon
186
iShares Gold Trust
IAU
$67.5B
$32K 0.01%
872
+143
+20% +$5.11K
KMB icon
187
Kimberly-Clark
KMB
$36.5B
$32K 0.01%
256
+105
+70% +$13.9K
TGT icon
188
Target
TGT
$68B
$32K 0.01%
+150
New +$32.5K
MCHP icon
189
Microchip Technology
MCHP
$46B
$31K 0.01%
408
– –
GLD icon
190
SPDR Gold Trust
GLD
$141B
$30K 0.01%
166
– –
SCHW
191
Charles Schwab
SCHW
$187B
$30K 0.01%
+350
New +$30.8K
VTEB icon
192
Vanguard Tax-Exempt Bond Index Fund
VTEB
$45.3B
$30K 0.01%
585
-3,139
-84% -$167K
DBC icon
193
Invesco DB Commodity Index Tracking Fund
DBC
$1.66B
$29K 0.01%
+1,106
New +$26.3K
COHR icon
194
Coherent
COHR
$74.2B
$28K 0.01%
+389
New +$26.5K
DIS icon
195
Walt Disney
DIS
$181B
$28K 0.01%
206
+101
+96% +$14.6K
FTNT icon
196
Fortinet
FTNT
$117B
$28K 0.01%
415
– –
HBI
197
DELISTED
Hanesbrands
HBI
$28K 0.01%
1,890
– –
NVDA icon
198
NVIDIA
NVDA
$5.42T
$28K 0.01%
1,040
+880
+550% +$22.1K
ROK icon
199
Rockwell Automation
ROK
$49B
$28K 0.01%
100
+97
+3,233% +$27.9K
TAN icon
200
Invesco Solar ETF
TAN
$1.49B
$28K 0.01%
374
– –
6 7
8
9 10

Similar funds

ICM
Innovator Capital Management Wheaton, Illinois $925M AUM 49.11% 1-Year Est. Return
TC
Tairen Capital Hong Kong $924M AUM 105.21% 1-Year Est. Return
CFA
Cahill Financial Advisors Edina, Minnesota $924M AUM 16.55% 1-Year Est. Return
GFG
Goldstone Financial Group Oakbrook Terrace, Illinois $922M AUM 14.34% 1-Year Est. Return
KI
Koch Inc Wichita, Kansas $922M AUM 16.65% 1-Year Est. Return
WC
Westerkirk Capital Victoria $929M AUM 21.93% 1-Year Est. Return
BCC
Biglari Capital Corp San Antonio, Texas $929M AUM 39.8% 1-Year Est. Return
TCM
Tyro Capital Management Miami, Florida $921M AUM 60.37% 1-Year Est. Return

Roble Belko & Company's Q1 2022 Portfolio in Review

As of Q1 2022, Roble Belko & Company held 409 positions worth $526M, down 1.2% from $532M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Roble Belko & Company deployed $19M of net new capital in Q1 2022, opening 43 new positions and adding to 73 existing holdings. Its largest new stake was Ares Commercial Real Estate: 140,452 shares worth $2.18M.

By sector, the portfolio is most concentrated in Real Estate at 3.1% of assets, up from 1.5% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Vanguard Ultra-Short Bond ETF, an estimated $16M trimmed.

  • Roble Belko & Company's largest Q1 2022 buy was Ares Commercial Real Estate: 140,452 shares worth $2.18M.
  • Roble Belko & Company added most to JPMorgan Ultra-Short Income ETF in Q1 2022, an estimated $13.9M increase.
  • Roble Belko & Company's biggest Q1 2022 reduction was Vanguard Ultra-Short Bond ETF, cutting an estimated $16M.
  • Roble Belko & Company fully exited Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF in Q1 2022, selling an estimated $381K.
  • Roble Belko & Company's ten largest holdings make up 52% of its $526M portfolio in Q1 2022.
  • Roble Belko & Company opened 43 new positions and closed 21 in Q1 2022.
  • Roble Belko & Company's portfolio value fell 1.2% quarter-over-quarter to $526M.

Based on Roble Belko & Company's 13F filing for Q1 2022, filed 6 May 2022.